PARK7 Human Gene Knockout Kit (CRISPR)
CAT#: KN201645RB
PARK7 - human gene knockout kit via CRISPR, HDR mediated
HDR-mediated knockout kit validation
USD 1,290.00
4 Weeks*
Specifications
Product Data | |
Format | 2 gRNA vectors, 1 GFP-puro donor, 1 scramble control |
Donor DNA | RFP-BSD |
Symbol | PARK7 |
Locus ID | 11315 |
Disclaimer | The kit is designed based on the best knowledge of CRISPR technology. The system has been functionally validated for knocking-in the cassette downstream the native promoter. The efficiency of the knock-out varies due to the nature of the biology and the complexity of the experimental process. |
Reference Data | |
RefSeq | NM_001123377, NM_007262 |
Synonyms | DJ-1; DJ1; HEL-S-67p |
Summary | The product of this gene belongs to the peptidase C56 family of proteins. It acts as a positive regulator of androgen receptor-dependent transcription. It may also function as a redox-sensitive chaperone, as a sensor for oxidative stress, and it apparently protects neurons against oxidative stress and cell death. Defects in this gene are the cause of autosomal recessive early-onset Parkinson disease 7. Two transcript variants encoding the same protein have been identified for this gene. [provided by RefSeq, Jul 2008] |
Documents
Product Manuals |
FAQs |
SDS |
Resources
Other Versions
SKU | Description | Size | Price |
---|---|---|---|
KN201645 | PARK7 - human gene knockout kit via CRISPR, HDR mediated |
USD 1,290.00 |
|
KN201645BN | PARK7 - human gene knockout kit via CRISPR, HDR mediated |
USD 1,290.00 |
|
KN201645LP | PARK7 - human gene knockout kit via CRISPR, HDR mediated |
USD 1,290.00 |
|
KN401645 | PARK7 - KN2.0, Human gene knockout kit via CRISPR, non-homology mediated. |
USD 1,290.00 |
|
GA107785 | PARK7 CRISPRa kit - CRISPR gene activation of human Parkinsonism associated deglycase |
USD 1,290.00 |
{0} Product Review(s)
Be the first one to submit a review